Suppr超能文献

HEHEHE 标记的亲和体分子可通过 IMAC 进行纯化,方便地用 [⁹⁹(m)Tc(CO)₃](+)进行标记,并表现出改善的生物分布,减少肝放射性积聚。

HEHEHE-tagged affibody molecule may be purified by IMAC, is conveniently labeled with [⁹⁹(m)Tc(CO)₃](+), and shows improved biodistribution with reduced hepatic radioactivity accumulation.

机构信息

Department of Medical Sciences, Uppsala University, Sweden.

出版信息

Bioconjug Chem. 2010 Nov 17;21(11):2013-22. doi: 10.1021/bc1002357. Epub 2010 Oct 22.

Abstract

Affibody molecules are a class of small (ca. 7 kDa) robust scaffold proteins suitable for radionuclide molecular imaging of therapeutic targets in vivo. A hexahistidine tag at the N-terminus streamlines development of new imaging probes by enabling facile purification using immobilized metal ion affinity chromatography (IMAC), as well as convenient ⁹⁹(m)Tc(CO)₃-labeling. However, previous studies in mice have demonstrated that Affibody molecules labeled by this method yield higher liver accumulation of radioactivity, compared to the same tracer lacking the hexahistidine tag and labeled by an alternative method. Two variants of the HER2-binding Affibody molecule Z(HER)₂(:)₃₄₂ were made in an attempt to create a tagged tracer that could be purified by immobilized metal affinity chromatography, yet would not result in anomalous hepatic radioactivity accumulation following labeling with ⁹⁹(m)Tc(CO)₃. In one construct, the hexahistidine tag was moved to the C-terminus. In the other construct, every second histidine residue in the hexahistidine tag was replaced by the more hydrophilic glutamate, resulting in a HEHEHE-tag. Both variants, denoted Z(HER)₂(:)₃₄₂-H₆ and (HE)₃-Z(HER)₂(:)₃₄₂, respectively, could be efficiently purified using IMAC and stably labeled with ⁹⁹(m)Tc(CO)₃ and were subsequently compared with the parental H₆-Z(HER)₂(:)₃₄₂ having an N-terminal hexahistidine tag. All three variants were demonstrated to specifically bind to HER2-expressing cells in vitro. The hepatic accumulation of radioactivity in a murine model was 2-fold lower with ⁹⁹(m)Tc(CO)₃-Z(HER2:342)-H₆ compared to ⁹⁹(m)Tc(CO)₃-H₆-Z(HER)₂(:)₃₄₂, and more than 10-fold lower with ⁹⁹(m)Tc(CO)₃-(HE)₃-Z(HER)₂(:)₃₄₂. These differences translated into appreciably superior tumor-to-liver ratio for ⁹⁹(m)Tc(CO)₃-(HE)₃-Z(HER)₂(:)₃₄₂ compared to the alternative conjugates. This information might be useful for development of other scaffold-based molecular imaging probes.

摘要

亲和体分子是一类小型(约 7 kDa)的刚性支架蛋白,适用于体内治疗靶点的放射性核素分子成像。N 端的六组氨酸标签通过使新的成像探针易于使用固定化金属离子亲和层析(IMAC)进行纯化,以及方便的 ⁹⁹(m)Tc(CO)₃标记,简化了其开发。然而,以前在小鼠中的研究表明,与缺乏六组氨酸标签且通过替代方法标记的相同示踪剂相比,用该方法标记的亲和体分子在肝脏中积累放射性更高。为了尝试创建一种可以通过固定金属亲和层析进行纯化的标记示踪剂,同时又不会导致用 ⁹⁹(m)Tc(CO)₃标记后肝脏放射性异常积聚,我们构建了两种 HER2 结合亲和体分子 Z(HER)₂(:)₃₄₂ 的变体。在一种构建体中,六组氨酸标签被移动到 C 端。在另一种构建体中,六组氨酸标签中的每两个组氨酸残基被更亲水的谷氨酸取代,形成 HEHEHE 标签。这两种变体分别表示为 Z(HER)₂(:)₃₄₂-H₆和(HE)₃-Z(HER)₂(:)₃₄₂,都可以通过 IMAC 进行有效纯化,并与具有 N 端六组氨酸标签的亲本 H₆-Z(HER)₂(:)₃₄₂稳定标记,随后与体外表达 HER2 的细胞进行比较。在小鼠模型中,与 ⁹⁹(m)Tc(CO)₃-H₆-Z(HER)₂(:)₃₄₂相比,⁹⁹(m)Tc(CO)₃-Z(HER2:342)-H₆的放射性在肝脏中的积累降低了 2 倍,而与 ⁹⁹(m)Tc(CO)₃-(HE)₃-Z(HER)₂(:)₃₄₂相比,降低了 10 倍以上。这些差异转化为 ⁹⁹(m)Tc(CO)₃-(HE)₃-Z(HER)₂(:)₃₄₂与其他缀合物相比,肿瘤与肝脏的比值明显更高。这些信息可能对其他支架基分子成像探针的开发有用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验